# The Pain Pen for Breakthrough Cancer Pain

> **NCT00125801** · PHASE3 · TERMINATED · sponsor: **Erasmus Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Neoplasms
- Pain

## Interventions

- **DRUG:** Subcutaneous hydromorphone delivered by pain pen

## Key facts

- **NCT ID:** NCT00125801
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-08
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** Lack of patients
- **Last updated:** 2008-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125801, "The Pain Pen for Breakthrough Cancer Pain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00125801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*